High-dose chemotherapy plus ASCT superior to standard immuno-chemotherapy in primary CNS lymphoma Presented ByProf. Gerald Illerhaus, Klinikum Stuttgart, Germany TrialPhase 3, MATRix/IELSG43 ConferenceASH 2022 20 February, 2023 12:37